Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of
death for individuals with diabetes is cardiovascular diseases, in part since both types of …

Abstract Purpose of Review An abnormal lipid profile is considered a main risk factor for
cardiovascular diseases and evidence suggests that single nucleotide polymorphisms …

High density lipoproteins (HDL) promote homeostasis and counteract stressful tissue
damage that underlie cardiovascular and other diseases by mediating reverse cholesterol …

Aims Free fatty acid receptor 4 (Ffar4) is a G-protein-coupled receptor for endogenous
medium-/long-chain fatty acids that attenuates metabolic disease and inflammation …

Nanodisc (ND)-forming membrane scaffold proteins or peptides developed from
apolipoprotein AI (apoA-I) have led to considerable promise in structural biology and …

Despite the ability of current efficacious low‐density lipoprotein‐cholesterol–lowering
therapies to reduce total cardiovascular disease (CVD) risks, CVD still poses major risks for …

Cardiovascular disease (CVD) in heterozygous familial hypercholesterolemia (HeFH), the
most frequent monogenic disorder of human metabolism, is largely driven by low-density …

Objective: We aimed at investigating the association of high-density lipoprotein subclasses
(HDL2-C and HDL3-C) levels with sleep duration, in comparison to other lifestyles in middle …